Ying-Xian Pan

Title: The Innovations of Ying-Xian Pan

Introduction

Ying-Xian Pan is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of biomedical research, particularly in the area of opioid receptors. With a total of 6 patents to his name, his work has the potential to impact therapeutic approaches to pain management.

Latest Patents

Ying-Xian Pan's latest patents include groundbreaking inventions related to mu-opioid receptor splice variant polypeptides and polynucleotides. One of his notable inventions encompasses novel splice variant forms of the mu-opioid receptor-1 (MOR-1) and the polynucleotide sequences encoding these MOR-1 splice variants. This invention also includes methods for screening compositions that regulate the activities of the MOR-1 splice variants. The regulation of these activities may significantly influence the physiological process of analgesia, offering new avenues for therapeutic modalities.

Career Highlights

Throughout his career, Ying-Xian Pan has worked at esteemed institutions such as the Sloan Kettering Institute for Cancer Research and the Memorial Sloan Kettering Cancer Center. His research has been pivotal in advancing our understanding of opioid receptors and their role in pain management.

Collaborations

Ying-Xian Pan has collaborated with notable professionals in his field, including Gavril W Pasternak. These collaborations have further enriched his research and contributed to the development of innovative solutions in pain therapy.

Conclusion

Ying-Xian Pan's contributions to the field of biomedical research, particularly through his patents on mu-opioid receptor splice variants, highlight his role as a leading inventor. His work continues to pave the way for advancements in pain management therapies.